| Schedule of Fair Value on Recurring Basis |
The
following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company’s assets that are measured
at fair value on a recurring basis as of June 30, 2026:
Schedule of Fair Value on Recurring Basis
| | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
| Assets: | |
| | | |
| | | |
| | |
| Note receivable | |
$ | - | | |
$ | - | | |
$ | 5,169,284 | |
The
following table presents, for each of the fair value hierarchy levels required under ASC 820, the Company’s assets and liabilities
that are measured at fair value on a recurring basis as of December 31, 2025:
| | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
| Assets: | |
| | | |
| | | |
| | |
| Note receivable | |
$ | - | | |
$ | - | | |
$ | 5,029,770 | |
| Liabilities: | |
| | | |
| | | |
| | |
| Warrant liability | |
$ | - | | |
$ | - | | |
$ | 1,881,078 | |
|
| Schedule of Changes in Fair Value |
The
following table presents the changes is the fair value of the Level 3 assets and liabilities:
Schedule of Changes in Fair Value
| | |
Note receivable | | |
Warrant liability | |
| Fair value as of December 31, 2025 | |
$ | 5,029,770 | | |
$ | 1,881,078 | |
| Change in valuation | |
| 139,514 | | |
| 3,790,225 | |
| Reclassification to equity | |
| - | | |
| (5,671,303 | ) |
| Balance as of June 30, 2026 | |
$ | 5,169,284 | | |
$ | - | |
|
| Schedule of Deferred Revenue |
The
following table presents the changes in the Company’s deferred revenue:
Schedule of Deferred Revenue
| | |
| | |
| Balance as of December 31, 2025 | |
$ | 721,897 | |
| Additions to deferred revenue | |
| 3,759,156 | |
| Revenue recognized from deferred revenue | |
| (3,692,555 | ) |
| Balance as of June 30, 2026 | |
$ | 788,498 | |
|
| Schedule of Earnings Per Share Basic and Diluted |
Schedule of Earnings Per Share Basic and Diluted
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Basic earnings (loss) per share computation: | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) (numerator) | |
$ | 888,740 | | |
$ | (3,618,969 | ) | |
$ | (4,650,611 | ) | |
$ | (21,022,555 | ) |
| Basic weighted-average number of common shares outstanding (denominator) | |
| 2,105,595 | | |
| 9,936 | | |
| 1,873,019 | | |
| 7,478 | |
| Basic earnings (loss) per common share | |
$ | 0.42 | | |
$ | (364.23 | ) | |
$ | (2.48 | ) | |
$ | (2,811.31 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted earnings (loss) per share computation: | |
| | | |
| | | |
| | | |
| | |
| Numerator | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) | |
$ | 888,740 | | |
$ | (3,618,969 | ) | |
$ | (4,650,611 | ) | |
$ | (21,022,555 | ) |
| Add interest expense on convertible notes, net of tax zero | |
| 16,683 | | |
| - | | |
| - | | |
| - | |
| Net income (loss) attributable to INVO for diluted earnings per share | |
| 905,423 | | |
| (3,618,969 | ) | |
| (4,650,611 | ) | |
| (21,022,555 | ) |
| Denominator | |
| | | |
| | | |
| | | |
| | |
| Weighted average shares | |
| 2,105,595 | | |
| 9,936 | | |
| 1,873,019 | | |
| 7,478 | |
| Add dilutive securities: | |
| | | |
| | | |
| | | |
| | |
| Warrants | |
| 153,750 | | |
| - | | |
| - | | |
| - | |
| Convertible debt and accrued interest | |
| 266,013 | | |
| - | | |
| - | | |
| - | |
| Convertible preferred | |
| 66,667 | | |
| - | | |
| - | | |
| - | |
| Diluted weighted-average number of common shares outstanding | |
| 2,592,025 | | |
| 9,936 | | |
| 1,873,019 | | |
| 7,478 | |
| Diluted net income (loss) per common share | |
$ | 0.35 | | |
$ | (364.23 | ) | |
$ | (2.48 | ) | |
$ | (2,811.31 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Anti-dilutive securities excluded: | |
| | | |
| | | |
| | | |
| | |
| Options | |
| 9,123 | | |
| 9,123 | | |
| 2,072 | | |
| 2,072 | |
| Warrants | |
| 1,898,020 | | |
| 2,051,770 | | |
| 528,334 | | |
| 528,334 | |
| Convertible debt and accrued interest | |
| - | | |
| 266,013 | | |
| 1,007,753 | | |
| 1,007,753 | |
| Convertible preferred stock | |
| - | | |
| 66,667 | | |
| 10,719 | | |
| 10,719 | |
|